Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma A Multicenter Observational Study in 443 Patients


Por: Martinez-Garcia, MA, Campos-Rodriguez, F, Nagore, E, Martorell, A, Rodriguez-Peralto, JL, Riveiro-Falkenbach, E, Hernandez, L, Banuls, J, Arias, E, Ortiz, P, Cabriada, V, Gardeazabal, J, Montserrat, JM, Carrera, C, Corral, J, Masa, JF, de Terreros, JG, Abad, J, Boada, A, Mediano, O, de Eusebio, E, Chiner, E, Landete, P, Mayos, M, Fortuna, A, Barbe, F, de la Torre, MS, de la Torre, AS, Cano, I, Gonzalez, C, Perez-Gil, A, Gomez-Garcia, T, Cullen, D, Somoza, M, Formigon, M, Aizpuru, F, Navarro, C, Selma-Ferrer, MJ, Garcia-Ortega, A, de Unamuno, B, Almendros, I, Farre, R and Gozal, D

Publicada: 1 dic 2018
Resumen:
BACKGROUND: Sleep-disordered breathing (SDB) has been associated with a greater incidence and mortality of cancer, although such findings are inconsistent. However, no large studies are currently available to investigate this association in patients with a specific type of cancer. This study seeks to assess potential relationships between SDB severity and aggressiveness markers of cutaneous melanoma. METHODS: Four hundred and forty-three patients with a diagnosis of melanoma underwent a sleep study within 6 months of diagnosis. General demographics were collected, along with melanoma characteristics and polygraphic parameters consisting of the apnea-hypopnea index (AHI) and indices of both continuous and intermittent night-time oxyhemoglobin desaturation (DI4%). An exploration of independent relationships between SDB and various objective melanoma aggressiveness markers (Breslow index, presence of ulceration, presence of regression, mitotic index, stage of severity, damage to the sentinel lymph, and spreading of the melanoma) was performed. RESULTS: Patients in the upper tertiles of AHI or DI4% were 1.94 (95% CI, 1.14-3.32; P = .022) and 1.93 (95% CI, 1.14-3.26; P = .013) times more likely, respectively, to present with aggressive melanoma (Breslow index > 1 mm) than those in the lowest tertiles of these sleep attributes after adjustment for age, sex, tumor location, and BMI. This association was particularly prominent among patients < 56 years of age with Breslow index > 2 mm. The presence of the additional markers of aggressiveness was also associated with higher AHI and DI4% values. CONCLUSIONS: The severity of SDB was independently associated with greater aggressiveness of cutaneous melanoma, particularly among younger patients.

Filiaciones:
Martinez-Garcia, MA:
 Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain

Campos-Rodriguez, F:
 Hosp Valme, Resp Dept, Seville, Spain

Nagore, E:
 Inst Valenciano Oncol, Dermatol Dept, Valencia, Spain

Martorell, A:
 Hosp Manises, Dermatol Dept, Valencia, Spain

Rodriguez-Peralto, JL:
 Hosp Univ 12 Octubre, Anat Pathol Dept, Madrid, Spain

Riveiro-Falkenbach, E:
 Hosp Univ 12 Octubre, Anat Pathol Dept, Madrid, Spain

Hernandez, L:
 Hosp Gen Univ Alicante, Resp Dept, Alicante, Spain

Banuls, J:
 Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain

Arias, E:
 Hosp Univ 12 Octubre, Resp Dept, Madrid, Spain

Ortiz, P:
 Hosp Univ 12 Octubre, Dermatol Dept, Madrid, Spain

Cabriada, V:
 Hosp Univ Cruces Bilbao, Resp Dept, Bilbao, Spain

Gardeazabal, J:
 Hosp Univ Cruces Bilbao, Dermatol Dept, Bilbao, Spain

Montserrat, JM:
 Hosp Clin IDIBAPS, Resp Dept, Barcelona, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Carrera, C:
 Hosp Clin IDIBAPS, Dermatol Dept, Barcelona, Spain

Corral, J:
 Hosp Univ San Pedro de Alcantara, Resp Dept, Caceres, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Masa, JF:
 Hosp Univ San Pedro de Alcantara, Resp Dept, Caceres, Spain

de Terreros, JG:
 Hosp Univ San Pedro de Alcantara, Resp Dept, Caceres, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

:
 Hosp Univ Germans Trials I Pujol, Resp Dept, Barcelona, Spain

:
 Hosp Univ Germans Trials I Pujol, Dermatol Dept, Barcelona, Spain

Mediano, O:
 Hosp Univ Gen Guadalajara, Resp Dept, Guadalajara, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

de Eusebio, E:
 Hosp Univ Gen Guadalajara, Dermatol Dept, Guadalajara, Spain

Chiner, E:
 Hosp Univ San Juan de Alicante, Resp Dept, Alicante, Spain

Landete, P:
 Hosp Univ San Juan de Alicante, Resp Dept, Alicante, Spain

Mayos, M:
 Hosp Univ Santa Creu & St Pau, Resp Dept, Barcelona, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Fortuna, A:
 Hosp Univ Santa Creu & St Pau, Resp Dept, Barcelona, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Barbe, F:
 IRBLleida, Resp Dept, Lleida, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

de la Torre, MS:
 IRBLleida, Resp Dept, Lleida, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

de la Torre, AS:
 IRBLleida, Resp Dept, Lleida, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Cano, I:
 Hosp Univ Getafe, Resp Dept, Madrid, Spain

Gonzalez, C:
 Hosp Univ Getafe, Dermatol Dept, Madrid, Spain

Perez-Gil, A:
 Hosp Valme, Dermatol Dept, Seville, Spain

Gomez-Garcia, T:
 Fdn Jimenez Diaz, Resp Dept, Madrid, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Cullen, D:
 Fdn Jimenez Diaz, Dermatol Dept, Madrid, Spain

Somoza, M:
 Consorcio Sanitario Terrassa, Resp Dept, Barcelona, Spain

Formigon, M:
 Consorcio Sanitario Terrassa, Dermatol Dept, Barcelona, Spain

Aizpuru, F:
 Univ Basque Country, OSI Araba Univ Hosp, Basque Hlth Serv, Biostat Serv,Hlth Res Inst,Bioaraba, Bilbao, Spain

Navarro, C:
 Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain

Selma-Ferrer, MJ:
 Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain

Garcia-Ortega, A:
 Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain

de Unamuno, B:
 Hosp Univ & Politecn la Fe, Dermatol Dept, Valencia, Spain

Almendros, I:
 Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Farre, R:
 Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain

 CIBER Enfermedades Resp, CIBERes, Madrid, Spain

Gozal, D:
 Univ Chicago, Dept Pediat, Chicago, IL 60637 USA

Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain.
Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.
ISSN: 00123692





Chest
Editorial
Elsevier Inc., RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Estados Unidos America
Tipo de documento: Article
Volumen: 154 Número: 6
Páginas: 1348-1358
WOS Id: 000452776800025
ID de PubMed: 30059679
imagen Green Accepted

MÉTRICAS